Therapix Biosciences Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0010951403
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- ILa | - |
|
08/07 | SciSparc Signs Non-Binding Letter of Intent to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio | MT |
03/06 | SciSparc Ltd. Secures Strategic Advantage with Grant of European Patent | CI |
Sales 2022 | 1.35 489.47 112.54 | Sales 2023 | 2.88 1.05K 240.53 | Capitalization | 2.56M 929M 214M |
---|---|---|---|---|---|
Net income 2022 | -2M -727M -167M | Net income 2023 | -5M -1.82B -418M | EV / Sales 2022 | 11,45,812 x |
Net cash position 2022 | 3.55M 1.29B 296M | Net cash position 2023 | 5M 1.82B 418M | EV / Sales 2023 | -8,48,893 x |
P/E ratio 2022 |
-1.33
x | P/E ratio 2023 |
-0.34
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
1st Jan change | Capi. | |
---|---|---|
+25.53% | 45.54B | |
+34.52% | 24.51B | |
+26.20% | 16.48B | |
+21.49% | 14.66B | |
+71.96% | 14.3B | |
-0.05% | 6.79B | |
-11.84% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |